Use of combined picosecond 1064nm and thulium laser 1927nm in melasma treatment – case report
DOI:
https://doi.org/10.12775/JEHS.2022.12.07.093Keywords
melasma, lasertherapy, hiperpigmentation, picosecond laser, thulium laserAbstract
Melasma is an acquired, chronic skin pigmentation disorder that affects mainly women and can significantly affect the quality of life and self-esteem of patients. Many therapeutic procedures have been described in the literature, nevertheless the disease is difficult to treat.
A case report. The paper presents a case of successful laser treatment in a 44-year-old woman with a long history of facial skin discoloration of the type of melasma. The patient was treated with combined laser therapy in the area of facial discoloration with a picosecond laser and a thulium laser.
Aim The aim of this study is to draw attention to the possibility of using laser therapy in the treatment of melasma-type skin hyperpigmentation. In this article, we describe a case of brightening of a melasma-type discoloration during a single laser treatment combining the use of a 1064nm picosecond laser and a 1927nm thulium laser, in order to meet interests of patients and physicians in the use of laserotherapy in the treatment of discoloration, especially in patients who do not tolerate well the side effects of pharmacological therapies.
Conclusions. The use of laser therapy, with particular emphasis on the picosecond and thulium laser, can be an important and effective element in the treatment of melasma-type hyperpigmentation of the skin.
References
Ball Arefiev KL, Hantash BM.: Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg, 2012;38:971-84.
Handel AC, Miot LD, Miot HA.: Melasma: a clinical and epidemiological review. An Bras Dermatol, 2014;89:771-82.
Hantash BM, Bedi VP, Sudireddy V, et al.:Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. J Biomed Opt, 2006;11:041115.
Hernández-Barrera R, Torres-Alvarez B, Castanedo-Cazares JP, et al.: Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma. Clin Exp Dermatol, 2008;33:305-8.
Ho SG, Yeung CK, Chan NP, et al.:A retrospective study of the management of Chinese melasma patients using a 1927 nm fractional thulium fiber laser. J Cosmet Laser Ther, 2013;15:200-6.
Kim DG, Nam SM, Shin JS, et al.: Effectiveness of the Picotoning Technique for the Treatment of Melasma with a Low Fluence 1,064-nm Nd:YAG Laser in Asian Patients. Medical Lasers, 2020;9:166-171.
Martin AG, Leal-Khouri S.: Physiologic skin changes associated with pregnancy. Int J Dermatol, 1992;31:375–378.
McKesey J, Tovar-Garza A, Pandya AG.: Melasma Treatment: An Evidence-Based Review. Am J Clin Dermatol, 2020;21(2):173-225.
Miot LD, Miot HA, Silva MG, et al.: Physiopathology of melasma. An Bras Dermatol,2009;84:623–635.
Polder KD, Bruce S.:Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study. Dermatol Surg, 2012;38:199-206.
Ramsdell WM. Fractional CO2 Laser Resurfacing Complications. Semin Plast Surg, 2012;26(3):137-140.
Rho N.: Treatment of Melasma Using a Novel 1,927 nm Fractional Thulium Laser: A Retrospective Analysis of 68 Korean Patients. Medical Lasers, 2017;6:10-16.
Rho NK.: Short- and long-term side effects of non-ablative fractional laser resurfacing in Koreans: analysis of 286 consecutive treatments. Med Laser, 2014;3:17-21.
Wong CSM, Chan MWM, Shek SYN, et al.: Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study. Lasers Surg Med, 2021;53(8):1032-1042.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Urszula Kozinska, Jordi Gras-Ozimek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 586
Number of citations: 0
